Skip to main content
S

StageZero Life Sciences Ltd. — Investor Relations & Filings

Ticker · SZLS.H ISIN · CA8525403017 LEI · 549300X4RIH613KZ1M68 TSX Human health and social work activities
Filings indexed 223 across all filing types
Latest filing 2026-01-27 Capital/Financing Update
Country CA Canada
Listing TSX SZLS.H

About StageZero Life Sciences Ltd.

StageZero Life Sciences Ltd. is a vertically integrated healthcare company dedicated to the development and commercialization of proprietary molecular diagnostic tests for early disease detection and management. The company specializes in blood-based diagnostics, often referred to as liquid biopsy, with a core mission to reduce the incidence of late-stage cancer through timely intervention. StageZero's offerings include the Aristotle multi-cancer panel test and associated health management services like AVRT. These services are often delivered through physician-led longevity clinics, integrating multiple health professionals with advanced diagnostic technology to provide comprehensive early detection strategies.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a 'Material Change Report' (Form 51-102F3) filed with the Ontario Securities Commission. It details a specific regulatory event (partial revocation of a cease trade order) and a subsequent financing plan. Since it is a formal regulatory filing regarding a material corporate event that does not fit into specific categories like M&A or Board changes, it falls under the general regulatory filing category.
2026-01-27 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate news release announcing a proposed private placement financing of up to $2.5 million via secured convertible debentures, permitted by a partial revocation of a cease trade order. It details the terms of the financing, regulatory approvals, use of proceeds and related procedural steps. This falls squarely under fundraising and capital structure updates rather than an earnings release, management discussion, or regulatory notice. Therefore, it is a Capital/Financing Update.
2026-01-21 English
News release - English.pdf
Delisting Announcement Classification · 1% confidence The document is a corporate press release announcing that StageZero’s public listing on the TSX will be terminated (delisted) and that it is applying for listing on the NEX Exchange. It provides details on the delisting date, rationale, regulatory context (FFCTO, OSC), and next steps for re-listing. This fits the definition of a Delisting Announcement (DLST).
2025-07-28 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a news release announcing a proposed private placement financing (issuance of non-convertible notes, convertible debentures, and warrants) with details on amounts, terms, use of proceeds, and regulatory approvals. It is not an annual or interim report, not an earnings release, nor a simple publication notice. It clearly relates to a fundraising/financing activity and capital structure change. Therefore, it falls under Capital/Financing Update (Code: CAP).
2025-05-07 English
Certificate and Articles of Amendment.pdf
Audit Report / Information Classification · 1% confidence The document is an auditor’s consent letter from Ernst & Young for incorporation by reference of their audit report into a securities prospectus. It is not the full annual report (10-K) nor a financing update by the company itself, but it is specifically related to the audit work and use of the audit report in an offering document. Therefore, it best fits the standalone Audit Report / Information category. FY 2024
2025-04-23 English
News release - English.pdf
Regulatory Filings
2024-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.